Disease | Micro RNA | Tissue/ Cell line | MicroRNA regulation | Targeted Member | More Details | References |
---|---|---|---|---|---|---|
Primary CNS lymphoma | hsa-miR-9 | Lymph node | Up | Overexpression of hsa-miR-9 activates Myc pathway in primary CNS lymphomas. | Fischer et al., 2011 | |
Primary CNS lymphoma | hsa-miR-17 | Lymph node | Up | Overexpression of hsa-miR-17 activates Myc pathway in primary CNS lymphomas. | Fischer et al., 2011 | |
Primary CNS lymphoma | hsa-miR-20a | Lymph node | Up | Overexpression of hsa-miR-20a activates Myc pathway in primary CNS lymphomas. | Fischer et al., 2011 | |
Primary CNS lymphoma | hsa-miR-20b | Lymph node | Up | Overexpression of hsa-miR-20b activates Myc pathway in primary CNS lymphomas. | Fischer et al., 2011 | |
Primary CNS lymphoma | hsa-miR-145 | Lymph node | Down | Downregulation of hsa-miR-145 is associated with Myc pathway in primary CNS lymphomas. | Fischer et al., 2011 | |
Hepatocellular carcinoma | hsa-miR-34a | Hepatocyte | Down | FOX M1 | hsa-miR-34a downregulates the expression of FoxM1 and c-Myc, which promotes telomerase activity and extends telomerase length in hepatocellular carcinoma. | Xu et al., 2015 |
Hepatocellular carcinoma | hsa-miR-34a | Hepatocyte | Down | MYC | hsa-miR-34a downregulates the expression of FoxM1 and c-Myc, which promotes telomerase activity and extends telomerase length in hepatocellular carcinoma. | Xu et al., 2015 |